Allergy Therapeutics (LON:AGY) Stock Price Down 6.1%

Allergy Therapeutics plc (LON:AGY) shares traded down 6.1% during trading on Monday . The stock traded as low as GBX 4.55 ($0.06) and last traded at GBX 4.60 ($0.06). 745,412 shares traded hands during mid-day trading, a decline of 16% from the average session volume of 883,358 shares. The stock had previously closed at GBX 4.90 ($0.06).

Allergy Therapeutics Stock Down 6.1 %

The firm has a fifty day moving average price of GBX 5.16 and a 200 day moving average price of GBX 3.66. The firm has a market capitalization of £219.42 million, a price-to-earnings ratio of -76.67, a P/E/G ratio of -30.70 and a beta of 1.34. The company has a current ratio of 1.40, a quick ratio of 1.48 and a debt-to-equity ratio of 37.22.

About Allergy Therapeutics

Allergy Therapeutics plc, a commercial biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics.